2018 Germany Hospital Infectious Disease Testing Market: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

Publisher Name :
Date: 09-Apr-2018
No. of pages: 897

This new report from VPGMarketResearch.com contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: 

  • Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms. 
  • Volume and sales forecasts for 80 infectious disease tests performed in German hospital laboratories. 
  • Instrumentation technologies and feature comparison of leading analyzers. 
  • Sales and market shares of leading suppliers. 
  • Emerging diagnostic technologies and their potential market applications. 
  • Product development opportunities. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for suppliers.

       Contains 897 pages and 74 tables

2018 Germany Hospital Infectious Disease Testing Market: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

Table of Contents

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
* Identification from Culture
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob's Disease
a. Background
b. Diagnostic Tests
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
Germany A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Germany Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Hospital Laboratories Performing Infectious Disease Tests by Bed Size
Germany Hospital Laboratories Infectious Disease Test Volume Forecast
Germany Hospital Laboratories Infectious Disease Diagnostics Market Forecast
Germany AIDS Testing Market Diagnostics Sales by Major Supplier
Germany Campylobacter Testing Market Diagnostics Sales by Major Supplier
Germany Candida Testing Market Diagnostics Sales by Major Supplier
Germany CMV Testing Market Diagnostics Sales by Major Supplier
Germany EBV Testing Market Diagnostics Sales by Major Supplier
Germany Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Germany Hepatitis Testing Market Diagnostics Sales by Major Supplier
Germany Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Germany Herpes Testing Market Diagnostics Sales by Major Supplier
Germany Influenza Testing Market Diagnostics Sales by Major Supplier
Germany Legionella Testing Market Diagnostics Sales by Major Supplier
Germany Meningitis Testing Market Diagnostics Sales by Major Supplier
Germany Mononucleosis Testing Market Diagnostics Sales by Major Supplier
Germany Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Germany Pneumonia Testing Market Diagnostics Sales by Major Supplier
Germany RSV Testing Market Diagnostics Sales Forecast by Major Supplier
Germany Rotavirus Testing Market Diagnostics Sales by Major Supplier
Germany Rubella Testing Market Diagnostics Sales by Major Supplier
Germany Septicemia Testing Market Diagnostics Sales by Major Supplier
Germany Streptococci Testing Market Diagnostics Sales by Major Supplier
Germany Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Germany Trichomonas Testing Market Diagnostics Sales by Major Supplier
Germany Tuberculosis Testing Market Diagnostics Sales by Major Supplier
  • Global Tuberculosis Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-May-2018        Price: US 3480 Onwards        Pages: 109
    Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night......
  • Global Point-of-Care Testing (POCT) Market Professional Survey Report 2018
    Published: 15-May-2018        Price: US 3500 Onwards        Pages: 126
    This report studies the global Point-of-Care Testing (POCT) market status and forecast, categorizes the global Point-of-Care Testing (POCT) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Point-of-Care Testing (POCT) market is valued at xx million US$ in 2017 and is......
  • United States Point-of-Care Testing (POCT) Market Report 2018
    Published: 23-Apr-2018        Price: US 3800 Onwards        Pages: 121
    In this report, the United States Point-of-Care Testing (POCT) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market shar......
  • Global Point-of-Care Testing (POCT) Sales Market Report 2018
    Published: 17-Apr-2018        Price: US 4000 Onwards        Pages: 123
    This report studies the global Point-of-Care Testing (POCT) market status and forecast, categorizes the global Point-of-Care Testing (POCT) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In 2017, the global Point-of-Care Testing (POCT) market size was xx million US$ and it is expected to ......
  • Global Point-of-Care Testing (POCT) Market Research Report 2018
    Published: 16-Apr-2018        Price: US 2900 Onwards        Pages: 127
    This report studies the global Point-of-Care Testing (POCT) market status and forecast, categorizes the global Point-of-Care Testing (POCT) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Point-of-Care Testing (POCT) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a......
  • China POC HbA1C Testing Market Research Report 2018
    Published: 10-Apr-2018        Price: US 3400 Onwards        Pages: 106
    The global POC HbA1C Testing market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the POC HbA1C Testing development status and future trend in China, focuses on top players in China, also splits POC HbA1C ......
  • Turkey POC HbA1C Testing Market Research Report 2018
    Published: 10-Apr-2018        Price: US 3400 Onwards        Pages: 114
    The global POC HbA1C Testing market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Turkey plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the POC HbA1C Testing development status and future trend in Turkey, focuses on top players in Turkey, also splits POC HbA......
  • China Rapid Influenza Diagnostic Tests Market Research Report 2018
    Published: 09-Apr-2018        Price: US 3400 Onwards        Pages: 108
    The global Rapid Influenza Diagnostic Tests market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Rapid Influenza Diagnostic Tests development status and future trend in China, focuses on top players in......
  • 2018 France Hospital Infectious Disease Testing Market: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 09-Apr-2018        Price: US 4450 Onwards        Pages: 897
    This new report from VPGMarketResearch.com contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Current scientific views on definition, epidemiolog......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs